Nima Nabavizadeh, MD

Dr. Nima Nabavizadeh is an Associate Professor of Radiation Medicine at the Oregon Health & Science University (OHSU), where he holds multiple roles in patient care, cutting-edge research and medical education. With a specialization in the treatment of gastrointestinal cancers, lymphomas and hematologic malignancies, he is known for his compassionate and understandable approach to patient care and his commitment to delivering state-of-the-art radiation therapy, tailored to each patients unique needs.

Dr. Nabavizadehs commitment to advancing cancer care extends beyond clinical practice. In his role as the Chief Medical Officer within the Cancer Early Detection Advanced Research Center (CEDAR) at OHSU, he is at the forefront of innovative early detection research initiatives. He serves as the Principal Investigator for a multitude of cancer early detection clinical trials, exploring novel strategies and technologies for identifying cancer at its earliest stages.

As the Radiation Oncology Residency Program Director at OHSU, Dr. Nabavizadeh plays a pivotal role in shaping the future of radiation oncology. He is responsible for mentoring and educating the next generation of radiation oncologists, ensuring that they receive the highest level of training and exposure to diverse clinical scenarios.

Throughout his career, Dr. Nabavizadeh has garnered recognition for his contributions to the field of radiation oncology. He has authored numerous peer-reviewed publications, presented at national and international conferences, and received grants that underscore his dedication to patient care, resident education and innovative research.

Disclosures:

• Employment: OREGON HEALTH & SCIENCE UNIVERSITY:Associate Professor of Radiation Oncology, Residency Program Director:Employee
• Compensation: GRAIL LLC: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: Present ;SAI-Med Partner: Consultant, Honoraria-End Date: Oct 2020 ;Freenome: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: present ;Pharmacy Times: Education Meeting Faculty-End Date: Present
• Ownership: none
• Leadership: none